These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18380736)

  • 21. [How I treat... An hepatocellular carcinoma: role of selective internal radiation therapy with intra-arterial iodine-131].
    Werenne X
    Rev Med Liege; 2007 Oct; 62(10):603-6. PubMed ID: 18069570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [131-I-lipiodol in therapy of liver carcinoma--methods and case report].
    Stefanović L; Nikolić V; Obradović M; Selir Z; Mihoci Z; Mihailović J; Malesević M
    Med Pregl; 2001; 54(7-8):387-90. PubMed ID: 11905192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between radioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma.
    Zeng ZC; Tang ZY; Yang BH; Liu KD; Wu ZQ; Fan J; Qin LX; Sun HC; Zhou J; Jiang GL
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1657-68. PubMed ID: 12458401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
    Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
    Konno T; Tabaru K; Isogai M; Nagamitsu A; Oda T
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma.
    De Ruyck K; Lambert B; Bacher K; Gemmel F; De Vos F; Vral A; de Ridder L; Dierckx RA; Thierens H
    J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Usefulness of hepatic arterial infusion chemotherapy using lecithin-added lipiodol emulsion in hepatocellular carcinoma].
    Kobayashi S; Koizumi S; Katagiri S; Ariizumi S; Takahashi Y; Otsubo T; Takasaki K; Yamamoto M
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1433-7. PubMed ID: 17876141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates.
    Keng GH; Sundram FX; Yu SW; Somanesan S; Premaraj J; Oon CJ; Kwok R; Htoo MM
    Ann Acad Med Singap; 2002 May; 31(3):382-6. PubMed ID: 12061301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma.
    Bhattacharya S; Novell JR; Dusheiko GM; Hilson AJ; Dick R; Hobbs KE
    Cancer; 1995 Dec; 76(11):2202-10. PubMed ID: 8635022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Yttrium-90 TheraSphere for the treatment of unresectable hepatocellular carcinoma.
    Liu MD; Uaje MB; Al-Ghazi MS; Fields D; Herman J; Kuo JV; Milne N; Nguyen TH; Ramsinghani NS; Tokita KM; Tsai FY; Vajgrt DJ; Imagawa DK
    Am Surg; 2004 Nov; 70(11):947-53. PubMed ID: 15586503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic artery injection of I-131-labeled lipiodol. Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases.
    Bretagne JF; Raoul JL; Bourguet P; Duvauferrier R; Deugnier Y; Faroux R; Ramée A; Herry JY; Gastard J
    Radiology; 1988 Aug; 168(2):547-50. PubMed ID: 2839867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular carcinoma and adjuvant intra-arterial [131I]Lipiodol.
    Launois B; Maddern G
    Br J Surg; 2002 Nov; 89(11):1345-6. PubMed ID: 12390371
    [No Abstract]   [Full Text] [Related]  

  • 33. Pilot study of transarterial chemoembolization with pirarubicin and amiodarone for unresectable hepatocellular carcinoma.
    Guiu B; Colin C; Cercueil JP; Loffroy R; Guiu S; Ferrant E; Jouve JL; Bonnetain F; Boulin M; Ghiringhelli F; Minello A; Hillon P; Bedenne L; Krause D; Chauffert B
    Am J Clin Oncol; 2009 Jun; 32(3):238-44. PubMed ID: 19349854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biodistribution and in vivo kinetics of iodine-131 lipiodol infused via the hepatic artery of patients with hepatic cancer.
    Nakajo M; Kobayashi H; Shimabukuro K; Shirono K; Sakata H; Taguchi M; Uchiyama N; Sonoda T; Shinohara S
    J Nucl Med; 1988 Jun; 29(6):1066-77. PubMed ID: 2836573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study.
    Brans B; De Winter F; Defreyne L; Troisi R; Vanlangenhove P; Van Vlierberghe H; Lambert B; Praet M; de Hemptinne B; Dierckx RA
    Cancer Biother Radiopharm; 2001 Aug; 16(4):333-8. PubMed ID: 11603004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Report of a pilot study of intra-arterial injection of I-131 lipiodol for the treatment of hepatoma.
    Lui WY; Liu RS; Chiang JH; Lo JG; Lai KH; King KL; Cheng HC; Wei YY; Chi CW; P'eng FK
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Sep; 46(3):125-33. PubMed ID: 2178041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol (Br J Surg 2003; 90: 1379-1383).
    Rai R; Rai S
    Br J Surg; 2004 Mar; 91(3):373; author reply 373. PubMed ID: 14991642
    [No Abstract]   [Full Text] [Related]  

  • 38. [Transcatheter internal radiotherapy of hepatoma using radioactive iodized oil (I-131 Lipiodol)].
    Kajiya Y; Nakajo M; Kobayashi H; Oyama T; Shinohara S
    Nihon Gan Chiryo Gakkai Shi; 1988 Apr; 23(4):815-21. PubMed ID: 2849622
    [No Abstract]   [Full Text] [Related]  

  • 39. 188Re-HDD/lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial.
    Lambert B; Bacher K; Defreyne L; Gemmel F; Van Vlierberghe H; Jeong JM; Dierckx RA; Van de Wiele C; Thierens H; De Vos F
    J Nucl Med; 2005 Jan; 46(1):60-6. PubMed ID: 15632035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transarterial infusion chemotherapy using cisplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
    Kawaoka T; Aikata H; Takaki S; Katamura Y; Hiramatsu A; Waki K; Takahashi S; Hieda M; Toyota N; Ito K; Chayama K
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):687-94. PubMed ID: 19444503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.